TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33629971

Group type: EXPERIMENTAL
Intervention: Weightlifting (WL) resistance training
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Plyometric (P) training
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (C) group
Number of subjects: 45
Study: 34554379

Group type: EXPERIMENTAL
Intervention: Bariatric Surgery (BSG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 0
Study: 32018166

Group type: EXPERIMENTAL
Intervention: EPA
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: DHA
Number of subjects: 21
Study: 35863559

Group type: EXPERIMENTAL
Intervention: Anakinra 100 mg, three times per week via the hemodialysis circuit for 24 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Anakinra
Number of subjects: 80
Study: 34521687

Group type: EXPERIMENTAL
Intervention: Natalizumab 300 mg IV every 4 weeks for 24 weeks
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo every 4 weeks for 24 weeks
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Natalizumab 300 mg IV
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 33472677

Group type: EXPERIMENTAL
Intervention: Mass drug administration (MDA) for soil-transmitted helminths (STH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention arm
Number of subjects: 0
Study: 34999593

Group type: EXPERIMENTAL
Intervention: info + prompt
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: info + plan
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: info + prompt + plan
Number of subjects: 240

Group type: COMPARATOR
Intervention: no prompt
Number of subjects: 240

Group type: COMPARATOR
Intervention: no plan
Number of subjects: 240
Study: 33388390

Group type: EXPERIMENTAL
Intervention: Mindful walking (MW) intervention plus a FitBit device
Number of subjects: 38

Group type: COMPARATOR
Intervention: FitBit device only
Number of subjects: 38
Study: 34812692

Group type: EXPERIMENTAL
Intervention: Mammography screening
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 33845881

Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (300 mg/kg equivalent to 20 gr as a slow single intravenous injection on the first day of hospitalization)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (Sterile water for injection, identical in appearance to N-Acetylcysteine)
Number of subjects: 40
Study: 33106170

Group type: EXPERIMENTAL
Intervention: BCG vaccinated group (200 participants)
Number of subjects: 400

Group type: COMPARATOR
Intervention: BCG unvaccinated control group (200 participants)
Number of subjects: 400
Study: 34847228

Group type: EXPERIMENTAL
Intervention: Deferiprone (n = 152)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Deferoxamine (n = 76)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Deferiprone
Number of subjects: 228
Study: 32781987

Group type: EXPERIMENTAL
Intervention: PDSAFE intervention
Number of subjects: 474

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 474
Study: 36075260

Group type: EXPERIMENTAL
Intervention: Rezvilutamide plus ADT (240 mg daily)
Number of subjects: 654

Group type: COMPARATOR
Intervention: Bicalutamide plus ADT (50 mg daily)
Number of subjects: 654
Study: 33004724

Group type: EXPERIMENTAL
Intervention: Audio Distraction
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Audiovisual Distraction (AVD) (VR)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Mobile Phone Game Distraction
Number of subjects: 60

Group type: COMPARATOR
Intervention: Tell‐Show‐Do (TSD)
Number of subjects: 60
Study: 35689084

Group type: EXPERIMENTAL
Intervention: Low-Dose atDCS
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: High-Dose atDCS
Number of subjects: 42

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Combined atDCS group (Low-Dose + High-Dose)
Number of subjects: 42
Study: 33932261

Group type: EXPERIMENTAL
Intervention: Long-term splinting (2-3 months)
Number of subjects: 512

Group type: COMPARATOR
Intervention: Short-term splinting (1 month or less)
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Long-term splinting
Number of subjects: 512

Group type: COMPARATOR
Intervention: Short-term splinting
Number of subjects: 512
Study: 36001383

Group type: EXPERIMENTAL
Intervention: Bevacizumab with standard platinum-based chemotherapy
Number of subjects: 413

Group type: COMPARATOR
Intervention: Standard platinum-based chemotherapy
Number of subjects: 413
Study: 32740081

Group type: EXPERIMENTAL
Intervention: 1 Hz translumbosacral neuromodulation therapy (TNT)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 5 Hz translumbosacral neuromodulation therapy (TNT)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 15 Hz translumbosacral neuromodulation therapy (TNT)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 1 Hz and 5 Hz translumbosacral neuromodulation therapy (TNT)
Number of subjects: 33
Study: 32118463

Group type: EXPERIMENTAL
Intervention: Daily text messages containing accurate drinking norms (n = 61)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Historical facts (control group, n = 60)
Number of subjects: 121
Study: 36394093

Group type: EXPERIMENTAL
Intervention: 5-session tDCS
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 20-session tDCS
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 36
Study: 34266574

Group type: EXPERIMENTAL
Intervention: Coexisting aortic dilations
Number of subjects: 14989

Group type: EXPERIMENTAL
Intervention: Coexisting iliac dilations
Number of subjects: 14989

Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 14989

Group type: EXPERIMENTAL
Intervention: Increasing body surface area
Number of subjects: 14989

Group type: EXPERIMENTAL
Intervention: Male sex
Number of subjects: 14989

Group type: EXPERIMENTAL
Intervention: Familial disposition
Number of subjects: 14989

Group type: EXPERIMENTAL
Intervention: Atrial fibrillation
Number of subjects: 14989

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 14989

Group type: EXPERIMENTAL
Intervention: Acute myocardial infarction
Number of subjects: 14989

Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 14989
Study: 33285079

Group type: EXPERIMENTAL
Intervention: Transbronchial lung cryobiopsy (TBLC)
Number of subjects: 65
Study: 32125382

Group type: EXPERIMENTAL
Intervention: Renal denervation and catheter ablation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Catheter ablation alone
Number of subjects: 0
Study: 33609182

Group type: EXPERIMENTAL
Intervention: Femoral nerve block (FNB)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Adductor canal block (ACB)
Number of subjects: 64
Study: 35972453

Group type: EXPERIMENTAL
Intervention: Progesterone vaginal tablets, 100 mg twice daily, starting from the day of embryo transfer
Number of subjects: 488

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 488
Study: 34120186

Group type: EXPERIMENTAL
Intervention: Dolutegravir
Number of subjects: 415
Study: 32538014

Group type: EXPERIMENTAL
Intervention: Traditional moxibustion
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Moxibustion light
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Moxibustion heat
Number of subjects: 216
Study: 33645069

Group type: EXPERIMENTAL
Intervention: Icaritin (5 μmol·L(‐1))
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Icaritin (10 μmol·L(‐1))
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Icaritin (20 μmol·L(‐1))
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 616905942

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Seated rest
Number of subjects: 30
Study: 34479850

Group type: EXPERIMENTAL
Intervention: Self-reported sleep hours
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Insomnia Severity Index (ISI) score
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Depression scores
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Insomnia severity
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Processing speed
Number of subjects: 221
Study: 32305457

Group type: EXPERIMENTAL
Intervention: Patient navigation services, shared patient registry, web-based social determinants of health platform
Number of subjects: 0
Study: 33338485

Group type: EXPERIMENTAL
Intervention: Low-intensity resistance exercise with long set configuration (LSC/LI-RE)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low-intensity resistance exercise with short set configuration (SSC/LI-RE)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Baseline measurements
Number of subjects: 10
Study: 32919416

Group type: EXPERIMENTAL
Intervention: H. pylori seropositive (1,044 participants, 55.4%)
Number of subjects: 1855
Study: 2000318910

Group type: EXPERIMENTAL
Intervention: Aprotinin (3 million KIU)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control (non-treated with aprotinin)
Number of subjects: 54
Study: 35232475

Group type: EXPERIMENTAL
Intervention: High-intensity functional training (HIFT) 1 day/week
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-intensity functional training (HIFT) 2 days/week
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-intensity functional training (HIFT) 3 days/week
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-intensity functional training (HIFT)
Number of subjects: 0
Study: 36207530

Group type: EXPERIMENTAL
Intervention: Hypertension digital therapeutics app with home BP monitoring (HBPM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group under physician management using HBPM and lifestyle modifications
Number of subjects: 0
Study: 34599495

Group type: EXPERIMENTAL
Intervention: Intervention plus usual care
Number of subjects: 227

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 227
Study: 35414714

Group type: EXPERIMENTAL
Intervention: Dynamic bedroom lighting (DD-N lighting)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard lighting system
Number of subjects: 30
Study: 33492457

Group type: EXPERIMENTAL
Intervention: Plasma intact fibroblast growth factor 23 (iFGF23) levels in XLH patients
Number of subjects: 18

Group type: COMPARATOR
Intervention: Plasma intact fibroblast growth factor 23 (iFGF23) levels in FS patients
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Phosphate levels in XLH patients
Number of subjects: 18

Group type: COMPARATOR
Intervention: Phosphate levels in FS patients
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: iPTH levels in XLH patients
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: TmP/GFR in XLH patients
Number of subjects: 18

Group type: COMPARATOR
Intervention: TmP/GFR in FS patients
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: eGFR in XLH patients
Number of subjects: 18

Group type: COMPARATOR
Intervention: eGFR in FS patients
Number of subjects: 18

Group type: COMPARATOR
Intervention: Hypercalciuria in FS patients
Number of subjects: 18
Study: 32700844

Group type: EXPERIMENTAL
Intervention: Amomum cardamom plant extract, 3 h exposure
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Curcuma mangga plant extract, 3 h exposure
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Various medicinal plant extracts, 3 h exposure
Number of subjects: 7
Study: 34304346

Group type: EXPERIMENTAL
Intervention: Targeted antibiotic prophylaxis based on rectal swab results
Number of subjects: 140

Group type: COMPARATOR
Intervention: Routine ciprofloxacin prophylaxis
Number of subjects: 140
Study: 34042572

Group type: EXPERIMENTAL
Intervention: Group A: propofol, remifentanil, and desflurane
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Group B: dexmedetomidine, remifentanil, and desflurane
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Group C: remifentanil and desflurane
Number of subjects: 21
Study: 33727034

Group type: EXPERIMENTAL
Intervention: Continuous regulation of tracheal cuff pressure using a pneumatic device
Number of subjects: 434

Group type: COMPARATOR
Intervention: Routine care (manual assessment three times daily using a portable manometer)
Number of subjects: 434
Study: 33081736

Group type: EXPERIMENTAL
Intervention: Culturally adapted diabetes self-management education intervention delivered by peer educators
Number of subjects: 48
Study: 35503024

Group type: EXPERIMENTAL
Intervention: Internet-based Cognitive Behavioral Therapy (ICBT) for 7 weeks
Number of subjects: 52

Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 52
Study: 32009486

Group type: EXPERIMENTAL
Intervention: 5-g oral collagen hydrolysate (CH) daily for 4 weeks
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 32974739

Group type: EXPERIMENTAL
Intervention: Rhinoplasty in patients with facial asymmetry
Number of subjects: 60

Group type: COMPARATOR
Intervention: Rhinoplasty in patients with symmetric faces
Number of subjects: 60
Study: 32623370

Group type: EXPERIMENTAL
Intervention: Drainage, irrigation and fibrinolytic therapy (DRIFT)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Standard treatment (control)
Number of subjects: 77
Study: 33863383

Group type: EXPERIMENTAL
Intervention: MSC treatment
Number of subjects: 22

Group type: COMPARATOR
Intervention: rituximab
Number of subjects: 22
Study: 32520439

Group type: EXPERIMENTAL
Intervention: Clinical medication review (CMR)
Number of subjects: 588

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 588
Study: 34011328

Group type: EXPERIMENTAL
Intervention: Interpersonal Community Psychiatric Treatment (ICPT)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Care As Usual (CAU)
Number of subjects: 93
Study: 33032474

Group type: EXPERIMENTAL
Intervention: Prodefen Plus® (synbiotic)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 151
Study: 36398114

Group type: EXPERIMENTAL
Intervention: Low-Intensity Vibration (LIV) - 0.4 g at 30 Hz for 10 min/day
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo device
Number of subjects: 20
Study: 32840458

Group type: EXPERIMENTAL
Intervention: Manual Therapy (MT)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Kinesio Taping following Manual Therapy (KTMT)
Number of subjects: 39
Study: 34058071

Group type: EXPERIMENTAL
Intervention: GDC-0334 (25 mg starting dose)
Number of subjects: 0
Study: 33475533

Group type: EXPERIMENTAL
Intervention: 0.5% concentration of povidone iodine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 1% concentration of povidone iodine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 3% concentration of povidone iodine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Saline-only controls
Number of subjects: 80
Study: 35536231

Group type: EXPERIMENTAL
Intervention: Journeying through Dementia intervention (n=191)
Number of subjects: 480

Group type: COMPARATOR
Intervention: Usual care (n=197)
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Journeying through Dementia intervention
Number of subjects: 480

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 480
Study: 33475753

Group type: EXPERIMENTAL
Intervention: Obstructive Sleep Apnea (OSA) diagnosed through polysomnography
Number of subjects: 4607

Group type: EXPERIMENTAL
Intervention: No OSA management or treatment
Number of subjects: 4607

Group type: EXPERIMENTAL
Intervention: OSA exposure time interval (short term, middle term, long term)
Number of subjects: 4607
Study: 36380290

Group type: EXPERIMENTAL
Intervention: Intervention for Appropriate Care and Treatment (InterACT) trial
Number of subjects: 0
Study: 35806937

Group type: EXPERIMENTAL
Intervention: Oral antiplatelet treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Natural wound healing (control group)
Number of subjects: 60
Study: 32332636

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) with basic western medicine (BWC)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Basic western medicine (BWC)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Sham electroacupuncture (sham EA) with basic western medicine (BWC)
Number of subjects: 150
Study: 34392795

Group type: EXPERIMENTAL
Intervention: Constraint‐induced movement therapy (CIMT) and neurostimulation paired with intensive, goal‐directed therapy
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 45
Study: 34168025

Group type: EXPERIMENTAL
Intervention: Interventions evaluated in randomised controlled trials
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Gallstone disease specific patient-reported outcome measures (PROMs)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Qualitative studies
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Primary qualitative research
Number of subjects: 129
Study: 32986748

Group type: EXPERIMENTAL
Intervention: Amaranth bread (150g containing 70% amaranth and 30% chickpea)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Maize bread (150g containing processed maize)
Number of subjects: 100
Study: 35617987

Group type: EXPERIMENTAL
Intervention: Multiplex bacterial PCR group
Number of subjects: 208

Group type: COMPARATOR
Intervention: Conventional microbiology control group
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 208
Study: 34137329

Group type: EXPERIMENTAL
Intervention: CT + SES
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: CT + NMES
Number of subjects: 90

Group type: COMPARATOR
Intervention: CT
Number of subjects: 90
Study: 32005160

Group type: EXPERIMENTAL
Intervention: 20 mL ropivacaine (7.5 mg/mL)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 20 mL saline (placebo)
Number of subjects: 60
Study: 35043250

Group type: EXPERIMENTAL
Intervention: AVJA + CRT-D
Number of subjects: 26

Group type: COMPARATOR
Intervention: CRT-D only
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Combined groups
Number of subjects: 26
Study: 32959591

Group type: EXPERIMENTAL
Intervention: Electroacupuncture combined with Yuyin pill
Number of subjects: 60

Group type: COMPARATOR
Intervention: Yuyin pill alone
Number of subjects: 60
Study: 36055440

Group type: EXPERIMENTAL
Intervention: Intermittent theta burst stimulation (iTBS) to left dorsolateral prefrontal cortex (LDLPFC)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Intermittent theta burst stimulation (iTBS) to right dorsolateral prefrontal cortex (RDLPFC)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 31
Study: 33423966

Group type: EXPERIMENTAL
Intervention: Chemotherapy with capecitabine for 6 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radiochemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stereotactic radiation therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemotherapy and radiochemotherapy
Number of subjects: 0
Study: 35767935

Group type: EXPERIMENTAL
Intervention: Topical aloe vera gel
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 120
Study: 34099659

Group type: EXPERIMENTAL
Intervention: Atezolizumab (anti-PD-L1) combined with chemotherapies
Number of subjects: 2616

Group type: EXPERIMENTAL
Intervention: High polygenic risk score (PRS) for lifetime risk of hypothyroidism
Number of subjects: 2616

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 2616
Study: 32417893

Group type: EXPERIMENTAL
Intervention: Standing position
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Sitting position
Number of subjects: 100
Study: 34070396

Group type: EXPERIMENTAL
Intervention: Low-GI diet
Number of subjects: 20

Group type: COMPARATOR
Intervention: Usual childcare diet (Control)
Number of subjects: 20
Study: 32343967

Group type: EXPERIMENTAL
Intervention: In‐Check DIAL device at Diskus (PIFD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: In‐Check DIAL device at HandiHaler (PIFHH)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: In‐Check DIAL device at zero resistance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repeatability limit for PIFD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repeatability limit for PIFHH
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modeling relationship between PIFD and PIFHH
Number of subjects: 0
Study: 34656781

Group type: EXPERIMENTAL
Intervention: Immobilization in external rotation (ER)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Immobilization in internal rotation (IR)
Number of subjects: 198
Study: 34730887

Group type: EXPERIMENTAL
Intervention: SHP block with bupivacaine injection
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control group with saline injection
Number of subjects: 115
Study: 32887591

Group type: EXPERIMENTAL
Intervention: Namaste Care Family program
Number of subjects: 231

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 231
Study: 34964679

Group type: EXPERIMENTAL
Intervention: Mobilization + Physical Therapy
Number of subjects: 56

Group type: COMPARATOR
Intervention: Physical Therapy
Number of subjects: 56
Study: 34881911

Group type: EXPERIMENTAL
Intervention: Dialectical behavior therapy for PTSD (DBT-PTSD)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Cognitive processing therapy (CPT)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: DBT-PTSD
Number of subjects: 93

Group type: COMPARATOR
Intervention: CPT
Number of subjects: 93
Study: 34799265

Group type: EXPERIMENTAL
Intervention: Virtual reality-supported vestibular rehabilitation program (30-min a day, 5 sessions per week, 15 sessions total for 3 weeks)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional vestibular rehabilitation program (30-min a day, 5 sessions per week, 15 sessions total for 3 weeks)
Number of subjects: 32
Study: 34928359

Group type: COMPARATOR
Intervention: Cisplatin-based CCRT (100 mg/m2 every 3 weeks for 3 cycles)
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Nedaplatin-based CCRT (100 mg/m2 every 3 weeks for 3 cycles)
Number of subjects: 402

Group type: COMPARATOR
Intervention: Cisplatin-based CCRT
Number of subjects: 402
Study: 32150478

Group type: EXPERIMENTAL
Intervention: Cold Snare Polypectomy (CSP)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Cold Snare Endoscopic Mucosal Resection (CS-EMR)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Endoscopic Mucosal Resection (EMR)
Number of subjects: 404
Study: 36416543

Group type: EXPERIMENTAL
Intervention: EE + DNG
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: EV + DNG
Number of subjects: 59

Group type: COMPARATOR
Intervention: DNG only
Number of subjects: 59

Group type: COMPARATOR
Intervention: EE + DNG vs EV + DNG
Number of subjects: 59